Diabetes at midlife influences risk of diabetes and cognitive decline in later years
the ONA take:
Substantial cognitive decline is associated with diabetes, prediabetes, and poor glucose control. The potential decline begins at midlife, when poor dietary habits and a lack of exercise leads to diabetes at approximately age 50 years.
These are the findings of a study by researchers at Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. The researchers analyzed data from the Atherosclerosis Risk in Communities Study involving 15,792 middle-age adults who had been followed since 1987.
The participants’ health was assessed approximately every 3 years, and a fifth assessment was conducted between 2011 and 2013. Three of the assessments included analysis of participants’ cognitive function. The rate of cognitive decline among the study participants was compared with age-related cognitive decline in the general population.
The researchers found that study participants with poorly controlled diabetes were 19% more likely to experience cognitive decline, or approximately 5 years sooner than healthy persons of the same age. The researchers conclude that to have a healthy brain at age 70 years, people need to eat right and exercise in their 50s.
Substantial cognitive decline is associated with diabetes, prediabetes, and poor glucose control.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|